HK-listed Venus Medtech hits 3-week high on $154 mln share sale

Venus Medtech (Hangzhou)

03/09/2020 03:47

** Shares of equipment maker for treatment of heart valve
diseases Venus Medtech (Hangzhou) Inc  2500.HK  rise as much as
13.7% to HK$74.50, their highest since Aug. 10
    ** Stock heads for the best day since listing on December
10, 2019
    ** The Chinese medical devices maker plans sale of 18.5 mln
new shares to third-party investors, raising HK$1.19 bln ($153.6
mln) for research and development, and for expansion of
operations and facilities (https://bit.ly/31Q4ujZ)
    ** New shares will be issued at HK$64.19 apiece,
representing a 2% discount to Wednesday's close of HK$65.5 each 
    ** The Hang Seng China enterprises index  .HSCE  climbs
0.6%, and the benchmark index  .HSI  gains 0.3%
    ** As of last close, the stock is up 74.7% this year 


($1 = 7.7500 Hong Kong dollars)

 (Reuters Messaging: donny.kwok.thomsonreuters.com@reuters.net)